These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33970787)

  • 21. Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report.
    Hollstein T; Schulte DM; Schulz J; Glück A; Ziegler AG; Bonifacio E; Wendorff M; Franke A; Schreiber S; Bornstein SR; Laudes M
    Nat Metab; 2020 Oct; 2(10):1021-1024. PubMed ID: 32879473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging roles of extracellular vesicles in COVID-19, a double-edged sword?
    Xia X; Yuan P; Liu Y; Wang Y; Cao W; Zheng JC
    Immunology; 2021 Aug; 163(4):416-430. PubMed ID: 33742451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 and Headache: A Primer for Trainees.
    Bobker SM; Robbins MS
    Headache; 2020 Sep; 60(8):1806-1811. PubMed ID: 32521039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in COVID-19 and diabetes.
    Govender N; Khaliq OP; Moodley J; Naicker T
    Prim Care Diabetes; 2021 Aug; 15(4):629-634. PubMed ID: 33849817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain.
    Francistiová L; Klepe A; Curley G; Gulya K; Dinnyés A; Filkor K
    Front Immunol; 2021; 12():730088. PubMed ID: 34484241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning β-cell survival and cardiovascular conditions in diabetic patients.
    Srivastava A; Rockman-Greenberg C; Sareen N; Lionetti V; Dhingra S
    Mol Cell Biochem; 2022 Jun; 477(6):1681-1695. PubMed ID: 35235124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
    Cabler SS; French AR; Orvedahl A
    Trends Mol Med; 2020 Dec; 26(12):1078-1085. PubMed ID: 33051104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic.
    Faruqi J; Balasubramanyam A
    Expert Rev Endocrinol Metab; 2023 Mar; 18(2):167-179. PubMed ID: 36797835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
    Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
    Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and diabetes: the contributions of hyperglycemia.
    Wang J; Meng W
    J Mol Cell Biol; 2020 Sep; 12(12):958-962. PubMed ID: 33002109
    [No Abstract]   [Full Text] [Related]  

  • 31. Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice.
    Ghasemzadeh M; Ghasemzadeh A; Hosseini E
    Hum Immunol; 2022 Jan; 83(1):86-98. PubMed ID: 34583856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection-Induction of Autoimmune Dysregulation and Metabolic Disturbances.
    Grubišić B; Švitek L; Ormanac K; Sabo D; Mihaljević I; Bilić-Ćurčić I; Omanović Kolarić T
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
    Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
    Front Immunol; 2021; 12():589095. PubMed ID: 33995341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Immediate and Long-Term Complication of COVID-19 May Be Type 2 Diabetes Mellitus: The Central Role of β-Cell Dysfunction, Apoptosis and Exploration of Possible Mechanisms.
    Hayden MR
    Cells; 2020 Nov; 9(11):. PubMed ID: 33202960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
    Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
    IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
    Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
    Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
    Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
    Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19.
    De Toma I; Dierssen M
    Sci Rep; 2021 Jan; 11(1):1930. PubMed ID: 33479353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: With Stops Along the Way in the Lung, Heart, Blood Vessels, and Adipose Tissue.
    Roy D; Ramasamy R; Schmidt AM
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):614-627. PubMed ID: 33327744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.